VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 783 filers reported holding VANECK VECTORS ETF TR in Q4 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,152,772 | +6.7% | 33,975 | -0.6% | 0.04% | 0.0% |
| Q1 2024 | $1,080,772 | +29.7% | 34,180 | +22.1% | 0.04% | +16.1% |
| Q4 2023 | $833,560 | +67.0% | 28,000 | +50.9% | 0.03% | +29.2% |
| Q3 2023 | $499,181 | -7.1% | 18,550 | +3.9% | 0.02% | -14.3% |
| Q2 2023 | $537,464 | +160.9% | 17,850 | +181.1% | 0.03% | +47.4% |
| Q1 2021 | $206,000 | -10.0% | 6,350 | 0.0% | 0.02% | -9.5% |
| Q4 2020 | $229,000 | -91.7% | 6,350 | -90.9% | 0.02% | -93.3% |
| Q3 2020 | $2,747,000 | +543.3% | 70,142 | +380.9% | 0.31% | +437.9% |
| Q4 2019 | $427,000 | +2.9% | 14,587 | -60.5% | 0.06% | -10.8% |
| Q3 2019 | $415,000 | +257.8% | 36,960 | +122.2% | 0.06% | +195.5% |
| Q1 2019 | $116,000 | – | 16,636 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |